This makes disposable health care products. It is expanding its empire by rapidly growing in emerging markets. Not facing the same kind of pressures from US politicians as other health care stocks. They have come up with a winning product, a drug coated balloon. This is not a cheap stock, but it is one that generates an ample amount of free cash flow, and one that could easily be swallowed by a company like Medtronic (MDT-N) or Johnson & Johnson (JNJ-N). Dividend yield of 0.47%.
Basically manufactures disposable health supplies that are used, thrown away, and then replenished. Due to the US Affordable Care Act, there are more and more people that are covered and are having operations. It has a bit of a moat in that it is hard to compete with. Also, came out with a balloon that is used in angioplasty and is covered with drugs. Dividend yield of 0.53%.
Bard C R Inc. is a OTC stock, trading under the symbol BCR-N on the (). It is usually referred to as or BCR-N
In the last year, there was no coverage of Bard C R Inc. published on Stockchase.
Bard C R Inc. was recommended as a Top Pick by on . Read the latest stock experts ratings for Bard C R Inc..
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
In the last year, there was no coverage of Bard C R Inc. published on Stockchase.
On , Bard C R Inc. (BCR-N) stock closed at a price of $.
(A Top Pick Sept 1/16. Up 44.47%.) Being acquired by Becton Dickinson (BDX-N). (See Top Picks.)